Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of berberine chloride in rats

Drug Development and Industrial Pharmacy

Volumn 39, Issue 9, 2013, Pages 1447-1456

  Fan, Dongjiao ^a   Wu, Xiaorong ^a   Dong, Wenna ^a   Sun, Wei ^b   Li, Jinzhuo ^b   Tang, Xing ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Berberine chloride; Gastrointestinal absorption enhancer; Local toxicity; Sodium caprate; Sodium deoxycholate

Indexed keywords

BERBERINE; DECANOATE SODIUM; DEOXYCHOLATE SODIUM; MEDIUM CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACT; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BERBERINE; BIOLOGICAL AVAILABILITY; DECANOIC ACIDS; DEOXYCHOLIC ACID; EXCIPIENTS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MAGNETIC RESONANCE SPECTROSCOPY; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; UP-REGULATION;

EID: 84881193571     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.723219     Document Type: Article

References (38)

1. Bova S, Padrini R, Goldman WF, Berman DM, Cargnelli G. (1992). On the mechanism of vasodilating action of berberine: possible role of inositol lipid signaling system. J Pharmacol Exp Ther, 261:318-323.
2. Chiou WF, Yen MH, Chen CF. (1991). Mechanism of vasodilatory effect of berberine in rat mesenteric artery. Eur J Pharmacol, 204:35-40.
3. Sun Y, Xun K, Wang Y, Chen X. (2009). A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs, 20:757-769.
4. Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N et al. (2008). Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab, 93:2559-2565. (Pubitemid 352008520)
5. Yin J, Xing H, Ye J. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metab Clin Exp, 57:712-717. (Pubitemid 351608234)
6. Zhang H, Wei J, Xue R, Wu JD, Zhao W, Wang ZZ et al. (2010). Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metab Clin Exp, 59:285-292.
7. Chen W, Miao YQ, Fan DJ, Yang SS, Lin X, Meng LK et al. (2011). Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech, 12:705-711.
8. Anderberg EK, Lindmark T, Artursson P. (1993). Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm Res, 10:857-864. (Pubitemid 23167568)
9. Sawada T, Ogawa T, Tomita M, Hayashi M, Awazu S. (1991). Role of paracellular pathway in nonelectrolyte permeation across rat colon epithelium enhanced by sodium caprate and sodium caprylate. Pharm Res, 8:1365-1371.
10. Pappenheimer JR. (1987). Physiological regulation of transepithelial impedance in the intestinal mucosa of rats and hamsters. J Membr Biol, 100:137-148. (Pubitemid 18004071)
11. Coyne CB, Kelly MM, Boucher RC, Johnson LG. (2000). Enhanced epithelial gene transfer by modulation of tight junctions with sodium caprate. Am J Respir Cell Mol Biol, 23:602-609.
12. Lindmark T, Kimura Y, Artursson P. (1998). Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther, 284:362-369. (Pubitemid 28109567)
13. Tomita M, Hayashi M, Awazu S. (1996). Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells. J Pharm Sci, 85:608-611. (Pubitemid 26179653)
14. Sharma P, Varma MV, Chawla HP, Panchagnula R. (2005). Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers. Farmaco, 60:884-893. (Pubitemid 41586262)
15. Lindmark T, Söderholm JD, Olaison G, Alván G, Ocklind G, Artursson P. (1997). Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate. Pharm Res, 14:930-935. (Pubitemid 27326990)
16. Dos Santos I, Fawaz F, Lagueny AM, Bonini F. (2003). Improvement of norfloxacin oral bioavailability by EDTA and sodium caprate. Int J Pharm, 260:1-4. (Pubitemid 36724856)
17. Salartash K, Gonze MD, Leone-Bay A, Baughman R, Sternbergh WC 3rd, Money SR. (1999). Oral low-molecular weight heparin and delivery agent prevents jugular venous thrombosis in the rat. J Vasc Surg, 30:526-531.
18. Sasaki K, Yonebayashi S, Yoshida M, Shimizu K, Aotsuka T, Takayama K. (2003). Improvement in the bioavailability of poorly absorbed glycyrrhizin via various non-vascular administration routes in rats. Int J Pharm, 265:95-102. (Pubitemid 37176950)
19. Guarini S, Ferrari W. (1985). Sodium deoxycholate promotes the absorption of heparin administered orally, probably by acting on gastrointestinal mucosa, in rats. Experientia, 41:350-352. (Pubitemid 15142965)
20. Chen Y, Lu Y, Chen J, Lai J, Sun J, Hu F et al. (2009). Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm, 376:153-160.
21. Samstein RM, Perica K, Balderrama F, Look M, Fahmy TM. (2008). The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. Biomaterials, 29:703-708. (Pubitemid 350181045)
22. Sharma P, Varma MV, Chawla HP, Panchagnula R. (2005). In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies. Farmaco, 60:874-883. (Pubitemid 41586261)
23. Bahar RJ, Stolz A. (1999). Bile acid transport. Gastroenterol Clin North Am, 28:27-58. (Pubitemid 29164086)
24. Sakai M, Imai T, Ohtake H, Azuma H, Otagiri M. (1997). Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy. J Pharm Sci, 86:779-785. (Pubitemid 27297487)
25. Hayashi M, Sakai T, Hasegawa Y, Nishikawahara T, Tomioka H, Iida A et al. (1999). Physiological mechanism for enhancement of paracellular drug transport. J Control Release, 62:141-148. (Pubitemid 29486492)
26. Battu SK, Repka MA, Maddineni S, Chittiboyina AG, Avery MA, Majumdar S. (2010). Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery. AAPS PharmSciTech, 11:1466-1475.
27. Maeng HJ, Yoo HJ, Kim IW, Song IS, Chung SJ, Shim CK. (2002). P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. J Pharm Sci, 91:2614-2621.
28. Pan GY, Wang GJ, Liu XD, Fawcett JP, Xie YY. (2002). The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol, 91:193-197. (Pubitemid 35216922)
29. Lv XY, Li J, Zhang M, Wang CM, Fan Z, Wang CY et al. (2010). Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine. AAPS PharmSciTech, 11:372-382.
30. Raoof AA, Ramtoola Z, McKenna B, Yu RZ, Hardee G, Geary RS. (2002). Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs. Eur J Pharm Sci, 17:131-138. (Pubitemid 35248266)
31. Bernstein C, Holubec H, Bhattacharyya AK, Nguyen H, Payne CM, Zaitlin B et al. (2011). Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol, 85:863-871.
32. Takahashi K, Murakami T, Yumoto R, Hattori T, Higashi Y, Yata N. (1994). Decanoic acid induced enhancement of rectal absorption of hydrophilic compounds in rats. Pharm Res, 11:1401-1404. (Pubitemid 24339645)
33. Lennernäs H, Gjellan K, Hallgren R, Graffner C. (2002). The influence of caprate on rectal absorption of phenoxymethylpenicillin: experience from an in-vivo perfusion in humans. J Pharm Pharmacol, 54:499-508. (Pubitemid 34308493)
34. Maher S, Kennelly R, Bzik VA, Baird AW, Wang X, Winter D et al. (2009). Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae. Eur J Pharm Sci, 38:291-300.
35. Cui HS, Hayasaka S, Zhang XY, Hayasaka Y, Chi ZL, Zheng LS. (2006). Effect of berberine on interleukin 8 and monocyte chemotactic protein 1 expression in a human retinal pigment epithelial cell line. Ophthalmic Res, 38:149-157. (Pubitemid 43780874)
36. Cui HS, Hayasaka S, Zhang XY, Hayasaka Y, Chi ZL, Zheng LS. (2007). Effect of berberine on barrier function in a human retinal pigment epithelial cell line. Jpn J Ophthalmol, 51:64-67. (Pubitemid 46281241)
37. Amasheh M, Fromm A, Krug SM, Amasheh S, Andres S, Zeitz M et al. (2010). TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling. J Cell Sci, 123:4145-4155.
38. Chao AC, Nguyen JV, Broughall M, Griffin A, Fix JA, Daddona PE. (1999). In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology. Int J Pharm, 191:15-24.